Protara Therapeutics, Inc. Cash and Cash Equivalents
Protara Therapeutics, Inc. (TARA) had Cash and Cash Equivalents of $17.08 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-08-11
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $17.08M.
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $14.74M.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $49.66M.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $12.55M.
| Period end | Cash and Cash Equivalents, at Carrying Value | Cash and Cash Equivalents, at Carrying Value as first filed |
|---|---|---|
| 2026-06-30 | $17.08M 10-Q · filed 2026-08-11 | |
| 2026-03-31 | $14.74M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $49.66M 10-Q · filed 2026-08-11 | |
| 2025-09-30 | $12.55M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $31.50M 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $91.46M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $162.80M 10-K · filed 2026-03-10 | |
| 2024-09-30 | $51.76M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $89.58M 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $52.23M 10-Q · filed 2024-05-02 | |
| 2023-12-31 | $39.59M 10-K · filed 2025-03-05 | |
| 2023-09-30 | $33.77M 10-Q · filed 2023-11-03 | |
| 2023-06-30 | $33.98M 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $21.04M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $24.13M 10-K · filed 2024-03-13 | |
| 2022-09-30 | $47.50M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $33.81M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $25.44M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $35.72M 10-K · filed 2023-03-08 | |
| 2021-09-30 | $40.74M 10-Q · filed 2022-11-03 | |
| 2021-06-30 | $46.84M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $58.20M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $168.60M 10-K · filed 2022-03-09 | |
| 2020-09-30 | $165.91M 10-Q · filed 2021-11-04 | $165.90M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $29.97M 10-Q · filed 2021-08-05 | $29.97M 10-Q · filed 2020-07-31 |
| 2020-03-31 | $36.07M 10-Q · filed 2020-05-13 | |
| 2019-12-31 | $564.00K 10-K · filed 2021-03-11 | $6.18M 10-K · filed 2020-03-20 |
| 2019-09-30 | $9.35M 10-Q · filed 2019-10-31 | |
| 2019-06-30 | $10.81M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $16.76M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $19.37M 10-K · filed 2020-03-20 | |
| 2018-09-30 | $18.23M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $12.48M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $25.36M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $21.17M 10-K · filed 2019-03-13 | |
| 2017-09-30 | $19.99M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $18.39M 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $34.13M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $36.39M 10-K · filed 2018-03-14 | |
| 2016-09-30 | $26.68M 10-Q · filed 2017-11-07 | |
| 2016-06-30 | $34.19M 10-Q · filed 2017-08-07 | |
| 2016-03-31 | $24.06M 10-Q · filed 2017-05-10 | |
| 2015-12-31 | $40.03M 10-K · filed 2018-03-14 | |
| 2015-09-30 | $35.98M 10-Q · filed 2016-11-07 | |
| 2015-06-30 | $16.82M 10-Q · filed 2016-08-08 | |
| 2015-03-31 | $9.78M 10-Q · filed 2016-05-09 | |
| 2014-12-31 | $68.84M 10-K · filed 2018-03-14 | |
| 2014-09-30 | $3.24M 10-Q · filed 2015-11-12 | |
| 2014-06-30 | $8.65M 10-Q · filed 2015-08-13 | |
| 2014-03-31 | $3.59M 10-Q · filed 2015-05-13 | |
| 2013-12-31 | $2.79M 10-K · filed 2017-03-16 | |
| 2013-09-30 | $6.86M 10-Q · filed 2014-11-25 | |
| 2012-12-31 | $2.41M 10-K · filed 2016-03-14 | |
| 2011-12-31 | $3.27M 10-K · filed 2015-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |